Horizon Discovery, ATCC Sign Distribution Deal for Cell Lines | GenomeWeb

NEW YORK (GenomeWeb News) – Horizon Discover today said it has signed a licensing and distribution deal with the American Type Culture Collection for certain sets of panels of X-Man isogenic cell lines.

ATCC will provide to its academic and not-for-profit customers certain Horizon products as part of, or in conjunction with, ATCC's Tumor Cell Panels. The deal is for non-commercial use only and excludes distribution in Japan or distribution of X-Man isogenic cell lines in isolation.

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.